Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks

Our study aims at providing evidence on patterns of use of biologic drugs for psoriasis in Tuscany, Italy. We conducted a drug-utilization study based on administrative databanks of Tuscany (EUPAS45365) from 2011 to 2019. We selected new users of etanercept, infliximab, adalimumab, ustekinumab, or s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of environmental research and public health 2022-06, Vol.19 (11), p.6799
Hauptverfasser:	Giometto, Sabrina, Tillati, Silvia, Baglietto, Laura, De Bortoli, Nicola, Mosca, Marta, Conte, Marco, Tuccori, Marco, Gini, Rosa, Lucenteforte, Ersilia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab - therapeutic use Biological products Biological Products - therapeutic use Clinical medicine Codes Data banks Dermatology Drugs Etanercept Etanercept - therapeutic use Female Human health and pathology Humans Infliximab Infliximab - therapeutic use Life Sciences Male Monoclonal antibodies Narcotics Patients Pharmaceutical sciences Pharmacology Psoriasis Psoriasis - drug therapy Psoriasis - epidemiology Quality of life Retrospective Studies Santé publique et épidémiologie Skin diseases Treatment Outcome Tumor necrosis factor-TNF Tumor necrosis factor-α Ustekinumab - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!